Clinical Trials for Myelofibrosis
Transform-1
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study Of Navitoclax In Combination With Ruxolitinib Versus Ruxolitinib In Subjects With Myelofibrosis. Click here to learn more.
- Clinical Trials
- Clinical Trials at UCBC
- Biliary Tract Cancer
- Bladder Cancer
- Brain & Spinal Cord Tumors
- Breast Cancer
- Cervical Cancer
- Colorectal Cancer
- Esophageal Cancer
- Gastric Tumors
- Head & Neck Cancer
- Kidney Cancer
- Lung Cancer
- Lymphoma
- Melanoma
- Multiple Myeloma
- Myelodysplastic Syndromes
- Myelofibrosis
- Neuroendocrine Tumors
- Ovarian Cancer
- Pancreatic Cancer
- Paroxysmal Nocturnal Hemoglobinuria
- Prostate Cancer
- Sarcoma Tumors
- Solid Tumors
- Uterine Cancer
